Unaudited Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023	$ 344,349	$ 46	$ 512,401	$ 665	$ (168,763)
Beginning balance (in shares) at Dec. 31, 2023		46,252,440
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	320,076	$ 5	320,071
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		5,397,301
Exercise of common stock options	1,657		1,657
Exercise of common stock options (in shares)		186,282
Vesting of restricted shares	5		5
Vesting of restricted shares (in shares)		4,548
Stock-based compensation	5,625		5,625
Unrealized gain (loss) on available-for-sale securities, net	(1,189)			(1,189)
Net loss	(14,760)				(14,760)
Ending balance at Mar. 31, 2024	655,763	$ 51	839,759	(524)	(183,523)
Ending balance (in shares) at Mar. 31, 2024		51,840,571
Beginning balance at Dec. 31, 2024	1,022,781	$ 59	1,258,316	2,163	(237,757)
Beginning balance (in shares) at Dec. 31, 2024		59,064,606
Exercise of common stock options	$ 901		901
Exercise of common stock options (in shares)	103,884	103,884
Stock-based compensation	$ 10,702		10,702
Unrealized gain (loss) on available-for-sale securities, net	1,593			1,593
Net loss	(23,508)				(23,508)
Ending balance at Mar. 31, 2025	$ 1,012,469	$ 59	$ 1,269,919	$ 3,756	$ (261,265)
Ending balance (in shares) at Mar. 31, 2025		59,168,490